| BackgroundBenign prostatic hyperplasia is a common urologic disease, most patients associated with chronic prostatitis. With frequent micturition, urgency, clinical dysuria and terminal micturition pain for the performance, some patients can be performed for the perineum, penis and lower abdominal pain. In recent years, many studies indicate that BPH is often accompanied by inflammatory changes, between the two has the relation of mutual induction. Prostatic hyperplasia patients due to prostatic duct mechanical obstruction and dilatation catheter wall, causing damage and ischemia, prostate fluid secretion stagnation, at the same time in nodules on the differentiation, maturation and infarction, reorganization in the occurrence and development of infection, can occur either chronic aseptic inflammation, promote glands inflammation worsen. While the prostatic inflammation exists to stimulate local release of growth factors, promotion of prostatic cell proliferation, induced by prostatic hyperplasia. In BPH with CP syndrome type distribution, according to the average Ridit value sorting, various types of prostate quality from large to small:Loss of card and kidney yang qi stagnation> yin deficiency syndrome>hot and humid place card>in the air subsidence card> Hyperactivity failure to declare, these tips BPH associated with CP patients, effects of prostate volume enlargement factor is still based on kidney deficiency, blood stasis for the standard; the TCM should be treated with Tonifying the kidney, blood stasis are the basic principles, Yishentong capsule for the first hospital of Guangzhou University of Chinese Medicine professor Cui Xuejiao Fang Cheng of old Chinese medicine experience preparation inside the courtyard, the side from Cistanche, Astragalus, semen Vaccariae, Eupatorium, the party has kidney qi, activating blood circulation to dissipate blood stasis effect, on benign prostatic hyperplasia with chronic prostatitis has cure effect.ObjectivesObservation of Yishen Capsule in treating benign prostate hyperplasia with chronic non bacterial prostatitis clinical effectMethods38cases of outpatient, inpatient department in line with standard diagnosed as benign prostatic hyperplasia with chronic prostatitis patients were divided into2groups, the experimental group20cases, oral Yishentong capsule,4, TID; the control group of18cases, oral prostat tablets,1capsules, bid. The study on the30day of ltherapy, treatment of2treatment courses. Recorded before and after the treatment of chronic prostatitis symptom score (NIH-CPSI score), the International Prostate Symptom Score (I-PSS score), maximal urinary flow rate (Max), abdominal B ultrasound in bladder residual urine volume (VPRV), using SPPSS17.0software package to handle the above data. Application of t inspection processing two samples data and application of chi-square test classification data.ResultAfter treatment in two groups of patients with chronic prostati tis symptom score and international prostate symptom score were decreased, abdominal B ultrasound and residual urine volume were reduced, the maximum urinary flow rate (Max) increased, compared with before treatment with significant difference (P<0.05) after treatment in the two groups, but no significant difference between the meaning of (P>0.05), suggesting that the two groups the same effect, the other in the study of clinical cases were observed in both the no obvious adverse reaction.GonclusionsYishentong capsule can improve with chronic prostatitis clinical symptoms in patients with benign prostatic hyperplasia. Its efficacy with prostat tablets efficacy equal... |
PDF Full Text Request